EUVIMEDEUVIMED entdecken
Crossref

Tetramethylpyrazine Targets HDAC6 ‐Mediated PINK1 Degradation to Alleviate Chronic Intermittent Hypoxia‐Induced Injury in Human Bronchial Epithelial Cells ( 16HBE )

Yanjie Chen, Hongye Chen, Zhixiong Huang, Mulan Deng, Xin Zheng, Qihui Chen iD

Chemical Biology & Drug Design · 2026-01 · 107 (1)

DOI: 10.1111/cbdd.70236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 18.01.2026. Verfasst von Yanjie Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Fuzhou Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Ch…. Hauptthemen laut MEDLINE: Pyrazines, Protein Kinases, Histone Deacetylase 6, Hypoxia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: the Natural Science Foundation of Fujian Province, Fuzhou Hospital of Traditional Chinese Medicine Science and Technology Program, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obstructive sleep apnea (OSA) is characterized by recurrent chronic intermittent hypoxia (CIH), which induces oxidative stress, inflammatory responses, and mitochondrial damage in bronchial epithelial cells. Tetramethylpyrazine (TMP) has been shown to exert lung‐protective effects in other pathological models, but its role in mitigating CIH‐induced 16HBE cell injury and the underlying molecular mechanisms have not been previously investigated. PTEN‐induced putative kinase 1 (PINK1)‐mediated mitophagy is a critical endogenous mechanism that defends against CIH‐induced epithelial damage. However, whether TMP alleviates CIH‐induced injury by regulating the PINK1 pathway remains unknown. CIH significantly reduced 16HBE cell viability, increased apoptosis rate, elevated inflammatory responses (IL‐6 and TNF‐α levels upregulated), and oxidative stress (ROS and MDA levels increased), and inhibited mitophagy (reduced PINK1 and LC3‐II/LC3‐I ratio, increased p62). TMP treatment improved cell viability in a dose‐dependent manner; notably, 20 μg/mL TMP reversed CIH‐induced apoptosis, inflammation, and oxidative stress, accompanied by upregulated PINK1 and restored mitophagy. Moreover, HDAC6 knockdown mimicked TMP's benefits (enhanced PINK1 and mitophagy, reduced injury), while concurrent PINK1 silencing reversed this effect. TMP protected 16HBE cells from CIH‐induced injury by inhibiting HDAC6‐mediated PINK1 deacetylation. This mechanism stabilized PINK1 protein, enhanced mitophagy, and thereby suppressed apoptosis, oxidative stress, and inflammation, identifying the HDAC6/PINK1 axis as a key regulatory pathway in CIH‐induced cell injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazinesProtein KinasesHistone Deacetylase 6HypoxiaHumansPTEN-Induced Putative KinaseEpithelial CellsCell LineApoptosisOxidative StressMitophagyBronchiCell SurvivalRNA, Small InterferingCell Hypoxia

Stichwörter der Autor:innen

PTEN‐induced putative kinase 1chronic intermittent hypoxiadeacetylationhistone deacetylase 6mitochondrial damageobstructive sleep apneatetramethylpyrazine

Substanzen

PyrazinesPTEN-Induced Putative KinaseProtein KinasesHistone Deacetylase 6tetramethylpyrazineHDAC6 protein, humanRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Fuzhou Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou City, Fujian, China.
  • Department of Traditional Chinese Medicine, The First Hospital of Putian City, Putian, Fujian, China.
  • Department of Acupuncture, Fuzhou Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou City, Fujian, China.

ORCID-Profile: Qihui Chen

Förderung

  • the Natural Science Foundation of Fujian Province
  • Fuzhou Hospital of Traditional Chinese Medicine Science and Technology Program
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Chen, Y., Chen, H., Huang, Z., Deng, M., Zheng, X., & Chen, Q. (2026). Tetramethylpyrazine Targets HDAC6 ‐Mediated PINK1 Degradation to Alleviate Chronic Intermittent Hypoxia‐Induced Injury in Human Bronchial Epithelial Cells ( 16HBE ). Chemical Biology & Drug Design, 107(1). https://doi.org/10.1111/cbdd.70236

Vancouver

Chen Y, Chen H, Huang Z, Deng M, Zheng X, Chen Q. Tetramethylpyrazine Targets HDAC6 ‐Mediated PINK1 Degradation to Alleviate Chronic Intermittent Hypoxia‐Induced Injury in Human Bronchial Epithelial Cells ( 16HBE ). Chemical Biology & Drug Design. 2026;107(1). doi:10.1111/cbdd.70236

BibTeX
@article{Chen2026,
  author = {Chen, Yanjie and Chen, Hongye and Huang, Zhixiong and Deng, Mulan and Zheng, Xin and Chen, Qihui},
  title = {Tetramethylpyrazine Targets HDAC6 ‐Mediated PINK1 Degradation to Alleviate Chronic Intermittent Hypoxia‐Induced Injury in Human Bronchial Epithelial Cells ( 16HBE )},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {1},
  doi = {10.1111/cbdd.70236}
}
Kostenlos starten →